Search
for
Sort by
Research 91–120 of 338
- Diagnosis of hyperandrogenism: clinical criteria
- Clinical and biological impact of the exposome on the skin
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Chemical Peels: Indications and Special Considerations for the Male Patient
- Potential applications of topical oxygen therapy in dermatology
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Compounding as a Current Therapeutic Option in Dermatology
- Controversial issues of hyperinfestation with Demodex mites in rosacea and acne
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Association of Acne Tarda with Endocrinological Disorders
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Skin Disorders in Athletes: Professional and Recreational Sports
- Disorders of the skin appendages
- Disease severity scoring systems in dermatology
- An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
- Un nuevo anovulador antiandrogénico
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Scarring Alopecia
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- The versatility of azelaic acid in dermatology
- SnapshotDx Quiz: January 2021
- “PRIDE” Complex
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities